Preclinical Data of ANAVEX 1-41 & ANAVEX 2-73 Show Highly Potent Anti-Amnesic & Neuroprotective...

Dr. Jean Jacques Bourguignon Joins Anavex Life Sciences Corp. Scientific Team

Anavex Life Sciences Corp. Announces Research Agreement with University of Paris 5-Rene Descartes

Anavex Life Sciences Corp. Announces its Preclinical Pipeline of Novel Oncology Therapies

Anavex Life Sciences Corp. Appoints VP Business Development and VP Strategic Planning

Anavex Life Sciences Corp. Outlines its Central Nervous System (CNS) Portfolio of Novel Therapeutics

Anavex Life Sciences Corp. Acquires a Portfolio of Patents and Appoints Dr. Alexandre Vamvakides CSO

Anavex Life Sciences Corp.: Appointment of CEO and Director